CARMAT SAS EURONEXT LONGCarmat SAS is a France-based Company engaged in the development and production of heart prosthesis.
enter price:25.8; stop-loss 23.30; target price 33.60.
Carmat's RSI looks strong and shows upwards momentum, therefore a drastic trend reversal or corrective pullback are unlikely to occur in the near future.
DMI the indicator in these situation can't be easily interpreted but we can identify a little bullish trend that is ready to growth.
MACD suggest that the graph is in a good bull trend.
The news told that Carmat has lunch its product in the U.S in 23 september. this fact can uphold our analysis.
NO FINANCIAL ADVISE
